Bullock James 4
Research Summary
AI-generated summary
Artivion (AORT) Director James Bullock Receives 7,576-Share Award
What Happened James Bullock, a director of Artivion, Inc. (AORT), received a grant of 7,576 restricted stock awards on May 18, 2026. The grant was reported at a $0.00 acquisition price (no cash exchanged) and is coded as an award/grant (A). The filing shows the award vests on May 18, 2027 under the company’s Equity and Cash Incentive Plan.
Key Details
- Transaction date: 2026-05-18; Form 4 filed 2026-05-20 (timely within the two-business-day window).
- Transaction type/code: Award/Grant (A).
- Shares granted: 7,576; reported acquisition price: $0.00; reported aggregate value: $0.
- Vesting: Per footnote, the RSA vests on May 18, 2027 under the Equity and Cash Incentive Plan.
- Shares owned after the transaction: not disclosed in this filing.
- No indication of 10b5-1 plan, tax withholding, or sale in this report.
Context This was a standard restricted stock award to a board member, not an open-market purchase or sale. Awards at $0.00 are common for compensation grants and generally vest over time; they do not by themselves indicate immediate buying or selling intent. Retail investors typically view grant disclosures as routine compensation actions unless accompanied by large purchases or sales.